INDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
申请人:UCB Biopharma SPRL
公开号:EP3303298A1
公开(公告)日:2018-04-11
Indazole Derivatives as Modulators of TNF Activity
申请人:UCB Biopharma SPRL
公开号:US20180222868A1
公开(公告)日:2018-08-09
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
[EN] INDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY<br/>[FR] DÉRIVÉS D'INDAZOLE SERVANT DE MODULATEURS DE L'ACTIVITÉ DU TNF
申请人:UCB BIOPHARMA SPRL
公开号:WO2016198401A1
公开(公告)日:2016-12-15
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.